A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants
Clinical trial NCT02813408 · COMPLETED
Trial details
- NCT number
- NCT02813408
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-03
- Primary completion
- 2018-03-21
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.